We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$2.81B
AUM Growth
-$708M
Cap. Flow
-$769M
Cap. Flow %
-27.37%
Top 10 Hldgs %
97.02%
Holding
18
New
–
Increased
3
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
ADAG
Adagene
ADAG
+$8.45M
2
THRD
Third Harmonic Bio
THRD
+$5.15M
3
GROV icon
Grove Collaborative
GROV
+$2.12M

Top Sells

Rank Stock Value
1
SQSP
Squarespace, Inc.
SQSP
+$493M
2
ALKT icon
Alkami Technology
ALKT
+$219M
3
BLND icon
Blend Labs
BLND
+$71.7M
4
SLRN
ACELYRIN
SLRN
+$941K

Sector Composition

Rank Sector Weight
1 Healthcare 45.01%
2 Technology 39.1%
3 Financials 12.49%
4 Consumer Staples 3.24%
5 Consumer Discretionary 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLO icon
1
dLocal
DLO
$4.34B
$720M 25.61%
63,906,695
– –
ALHC icon
2
Alignment Healthcare
ALHC
$3.72B
$686M 24.43%
60,993,323
– –
ALKT icon
3
Alkami Technology
ALKT
$1.96B
$354M 12.59%
9,645,318
-5,875,000
-38% -$219M
XP icon
4
XP
XP
$8.5B
$351M 12.49%
29,617,733
– –
CNTA
5
DELISTED
Centessa Pharmaceuticals
CNTA
$162M 5.77%
9,681,818
– –
AKRO
6
DELISTED
Akero Therapeutics
AKRO
$146M 5.18%
5,233,989
– –
PHVS icon
7
Pharvaris
PHVS
$2.34B
$144M 5.14%
7,531,252
– –
EWCZ
8
DELISTED
European Wax Center
EWCZ
$87.4M 3.11%
13,110,492
– –
RPRX icon
9
Royalty Pharma
RPRX
$26.6B
$38.3M 1.36%
1,500,000
– –
IMCR icon
10
Immunocore
IMCR
$1.7B
$37.2M 1.32%
1,261,684
– –
THRD
11
DELISTED
Third Harmonic Bio
THRD
$34.7M 1.24%
3,372,323
+413,561
+14% +$5.15M
RSKD icon
12
Riskified
RSKD
$731M
$25.2M 0.9%
5,324,998
– –
SLRN
13
DELISTED
ACELYRIN
SLRN
$8.46M 0.3%
2,695,327
-194,341
-7% -$941K
ADAG
14
Adagene
ADAG
$245M
$7.61M 0.27%
3,825,952
+3,561,952
+1,349% +$8.45M
LOGC
15
DELISTED
ContextLogic
LOGC
$4.29M 0.15%
609,616
– –
GROV icon
16
Grove Collaborative
GROV
$45.8M
$3.44M 0.12%
2,474,859
+1,538,839
+164% +$2.12M
BLND icon
17
Blend Labs
BLND
$433M
– –
-19,132,440
Closed -$71.7M
SQSP
18
DELISTED
Squarespace, Inc.
SQSP
– –
-10,611,073
Closed -$493M

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q4 2024 Portfolio in Review

As of Q4 2024, General Atlantic held 18 positions worth $2.81B, down 20% from $3.52B the previous quarter. Its ten largest holdings account for 97% of the portfolio.

General Atlantic withdrew a net $769M in Q4 2024, closing 2 positions and reducing 2 holdings. Its most notable exit was Squarespace, Inc., an estimated $493M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 37% a quarter earlier, followed by Technology and Financials.

Against the trend, General Atlantic added an estimated $8.45M to Adagene.

  • General Atlantic added most to Adagene in Q4 2024, an estimated $8.45M increase.
  • General Atlantic's biggest Q4 2024 reduction was Alkami Technology, cutting an estimated $219M.
  • General Atlantic fully exited Squarespace, Inc. in Q4 2024, selling an estimated $493M.
  • General Atlantic's ten largest holdings make up 97% of its $2.81B portfolio in Q4 2024.
  • General Atlantic opened 0 new positions and closed 2 in Q4 2024.
  • General Atlantic's portfolio value fell 20% quarter-over-quarter to $2.81B.

Based on General Atlantic's 13F filing for Q4 2024, filed 7 Feb 2025.